Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Ferrostatin-1 (Fer-1) in Translational Ferroptosis Research
2026-06-15
Explore how Ferrostatin-1 (Fer-1) reshapes ferroptosis research, offering deep insights into oxidative lipid damage inhibition and advanced disease modeling. This article uniquely bridges mechanistic science and assay innovation, with practical takeaways for cancer and neurodegeneration studies.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Protein
2026-06-14
Preserve protein integrity in complex biological samples using APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). Unlock advanced workflows for phosphorylation-sensitive assays and troubleshoot common pitfalls with parameter-driven guidance.
-
Gingerenone A Reverses Sunitinib Resistance in Renal Cell Ca
2026-06-13
This study reveals that gingerenone A, a phenolic compound from ginger, inhibits LDHA-driven glycolysis and restores sunitinib sensitivity in renal cell carcinoma (RCC) models. The findings highlight a metabolic co-targeting strategy to overcome resistance to multi-targeted receptor tyrosine kinase inhibitors in RCC research.
-
GPR35-KLF5 Circuitry Directs Mucosal Repair in DSS Colitis M
2026-06-12
This study uncovers a tryptophan metabolic sensing mechanism in which GPR35 detects mucosal damage and activates KLF5-driven repair in intestinal epithelial cells. The findings clarify how epithelial cells decode injury signals, offering mechanistic insight for improving ulcerative colitis research and therapies using DSS-induced mouse models.
-
Live-Dead Cell Staining Kit: Reliable Viability for Modern L
2026-06-12
This article delivers a scenario-driven, evidence-based guide for researchers seeking reproducible and quantitative cell viability analysis. Grounded in real-world laboratory challenges, it demonstrates how the Live-Dead Cell Staining Kit (SKU K2081) from APExBIO empowers precise Calcein-AM Propidium Iodide staining for applications ranging from cytotoxicity testing to advanced biomaterials evaluation.
-
SLC11A1 Drives TGF-β1 Pathway to Resist Ferroptosis in CRC
2026-06-11
A recent study demonstrates that SLC11A1 overexpression activates the TGF-β1 signaling pathway, promoting resistance to ferroptosis and enhancing malignancy in colorectal cancer cells. These findings reveal SLC11A1 as a mechanistic driver of cell survival and a potential therapeutic target in colorectal cancer.
-
Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Rese
2026-06-11
Ferrostatin-1 (Fer-1) enables precise modulation of ferroptosis in cancer biology and neurodegeneration models, acting as a nanomolar inhibitor of oxidative lipid damage. Explore advanced experimental workflows, troubleshooting insights, and the translational impact of Fer-1 in overcoming drug resistance and refining ferroptosis assays.
-
LY294002: Precision Control of PI3K Signaling and Synaptic M
2026-06-10
Explore LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, and its unique role in dissecting synaptic plasticity and cellular processes beyond conventional cancer research. This article provides advanced insights and practical assay guidance not found in existing resources.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni
2026-06-10
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables reliable, high-yield synthesis of randomly Cy3-labeled RNA probes for applications such as in situ hybridization and Northern blotting. It is designed for research workflows requiring sensitive fluorescent RNA detection, and is not validated for diagnostic or therapeutic use.
-
Cytochalasin D: Mechanistic Insights and Translational Front
2026-06-09
Explore Cytochalasin D as an actin polymerization inhibitor, uncovering its unique mechanisms of action, impact on cell cycle arrest, and advanced applications in cancer and viral research. This article provides an in-depth, evidence-backed analysis with fresh insights beyond standard protocols.
-
Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi
2026-06-09
Anlotinib hydrochloride delivers next-generation, multi-target tyrosine kinase inhibition for precise anti-angiogenic and tumor proliferation research. This article unpacks practical workflows, troubleshooting strategies, and translational insights to maximize assay performance and data reproducibility.
-
Cabozantinib (XL184): Multi-Kinase Inhibition Beyond RCC Res
2026-06-08
Discover how Cabozantinib (XL184) disrupts multiple signaling pathways in cancer research, with new insights into chronic adaptation and phosphoproteomic remodeling. This article offers a deeper perspective on antiangiogenic strategy and kinase network rewiring.
-
Vitamin D/VDR Enhances Endometrial Decidualization via Estro
2026-06-08
This study elucidates how vitamin D, through its receptor VDR, promotes decidualization in human endometrial stromal cells by directly regulating estrogen biosynthesis and receptor expression. The findings provide mechanistic insight with potential applications for infertility research and advanced modeling of endometrial physiology.
-
Cardamomin Protects Against Oxidative Damage in Ischemic Str
2026-06-07
This study demonstrates that cardamomin, a chalcone from Amomum villosum, confers neuroprotection by mitigating oxidative damage and inhibiting cell death pathways in models of cerebral ischemic stroke. The findings highlight mechanistic links between cardamomin, NRF2 activation, and mitochondrial function, providing a foundation for future translational research in ischemic injury and neuroprotection.
-
Anlotinib Hydrochloride: Advancing Multi-Target Tyrosine Kin
2026-06-06
Anlotinib hydrochloride empowers researchers with nanomolar potency and reliable inhibition of VEGFR2, PDGFRβ, and FGFR1, outperforming other multi-target tyrosine kinase inhibitors in angiogenesis and tumor cell migration models. Its unique selectivity profile and favorable safety make it a robust tool for dissecting ERK pathway inhibition and optimizing cancer research workflows.